C3.ai Digital Transformation Institute Announces Research Awards for AI to Transform Cybersecurity and Secure Critical Infrastructure
24.3.2022 13:00:00 EET | Business Wire | Press release
C3.ai Digital Transformation Institute (C3.ai DTI) today announced the third round of C3.ai DTI funded advanced research awards, focused on using artificial intelligence (AI) to harden information security and secure critical infrastructure.
The Institute awarded a total of $6.5 million in cash awards to leading research scientists at University of California, Berkeley, University of Illinois at Urbana-Champaign, Carnegie Mellon, Princeton, University of Chicago, KTH Royal Institute of Technology, and MIT.
“Cybersecurity is an immediate existential issue,” said Thomas M. Siebel, chairman and CEO of C3 AI, a leading enterprise AI software provider. “We are equipping top scientists with the means to advance technology to help secure critical infrastructure.”
Twenty-four projects were awarded $100,000 to $700,000 each, for an initial period of one year:
AI Resilience: Techniques and methods to enable the development of AI algorithms that are resilient to adversarial attacks
- “High Performance Provably Robust AI Methods for Cybersecurity Tasks on Critical Infrastructure,” (Zico Kolter, Carnegie Mellon University)
- “Scalable, Secure Machine Learning in the Presence of Adversaries,” (John Kubiatowicz, University of California, Berkeley)
- “REFL: Resilient Distributed Cybersecurity Learning System,” (Bo Li, University of Illinois at Urbana-Champaign)
- “Fundamental Limits on the Robustness of Supervised Machine Learning Algorithms,” (Ben Zhao, University of Chicago)
Anomaly Detection: AI techniques, including supervised and unsupervised learning, to provide early detection of system and/or network anomalies that might be indicative of unauthorized access, denial of service, or data exfiltration
- “Continuously and Automatically Discovering and Remediating Internet-Facing Security Vulnerabilities,” (Nick Feamster, University of Chicago)
- “AI Techniques for Power Systems Under Cyberattacks,” (Javad Lavaei, University of California, Berkeley)
- “Physics-aware AI-based Approach for Cyber Intrusion Detection in Substation Automation Systems,” (Alberto Sangiovanni-Vincentelli, University of California, Berkeley)
Advanced Persistent Threats: AI techniques to detect the presence of advanced persistent threats
- “Deep-Learning Detection Algorithms for Advanced Persistent Attacks in Mixed-Autonomy Traffic: Design and Experimental Validation,” (Alex Bayen, University of California, Berkeley)
- “AI Support for Cybersecurity,” (David Wagner, University of California, Berkeley)
Securing Critical Cyber-Physical Infrastructure: AI techniques to secure critical infrastructure against cyber threats
- “Cyber Safety Cage for Networks,” (Cyrille Valentin Artho, KTH Royal Institute of Technology)
- “Security for Large-Scale Infrastructure using Probabilistic Programming,” (Nikita Borisov, University of Illinois at Urbana-Champaign)
- “A Compositional Neural Certificate Framework for Securing Critical Networked Infrastructure,” (Chuchu Fan, Massachusetts Institute of Technology)
- “Democratizing AI-Driven Security Workflows for Critical Energy Infrastructure,” (Vyas Sekar, Carnegie Mellon University)
- “Semantic Adversarial Analysis for Secure Critical Infrastructure,” (Sanjit Seshia, University of California, Berkeley)
Forensics: AI forensics and attribution techniques to identify sources of attacks
- “Causal Reasoning for Real-Time Attack Identification in Cyber-Physical Systems,” (György Dán, KTH Royal Institute of Technology)
- “Statistical Learning Theory and Graph Neural Networks for Identifying Attack Sources,” (H. Vincent Poor, Princeton University)
- “Robust and Scalable Forensics for Deep Neural Networks,” (Ben Zhao, University of Chicago)
Securing Emerging Financial Infrastructure: AI techniques to identify attacks on emerging decentralized financial and business infrastructure
- “An Intelligence Platform for Better Security in Decentralized Finance,” (Dawn Song, University of California, Berkeley)
- “Blockchain Forensics,” (Pramod Viswanath, University of Illinois at Urbana-Champaign)
Vulnerability Identification: AI techniques to identify previously unknown malware, ransomware, and zero-day vulnerabilities, enabling isolation and neutralization
- “GAN-Aided Automatic Test Case Generation,” (Giulia Fanti, Carnegie Mellon University)
- “Machine Learning for JavaScript Vulnerability Detection,” (Corina Pasareanu, Carnegie Mellon University)
Insider Threats: Change management techniques to prevent the weaponization of innocent and malicious insiders
- “Protecting Critical Infrastructures Against Evolving Insider Threats,” (Carl Gunter, University of Illinois at Urbana-Champaign)
- “Multi-Facet Rare Event Modeling of Adaptive Insider Threats,” (Jingrui He, University of Illinois at Urbana-Champaign)
- “AI-Supported Nudging for Cyber-Hygiene,” (Cedric Langbort, University of Illinois at Urbana-Champaign)
Award Criteria
C3.ai DTI selects research proposals that inspire cooperative research and advance machine learning and other AI subdisciplines. Projects are peer-reviewed on scientific merit, prior accomplishments of the principal investigator and co-principal investigators, the use of AI, machine learning, data analytics, and cloud computing in the research project, and the suitability for testing the methods at scale. Visit C3DTI.ai to learn more about the Institute’s programs, award opportunities, and selected research proposals.
About C3.ai Digital Transformation Institute
Established in March 2020 by C3 AI, Microsoft, and leading universities, the C3.ai Digital Transformation Institute is a research consortium dedicated to accelerating the benefits of artificial intelligence for business, government, and society. The Institute engages the world’s leading scientists to conduct research and train practitioners in the new Science of Digital Transformation — operating at the intersection of artificial intelligence, machine learning, cloud computing, internet of things, big data analytics, organizational behavior, public policy, and ethics.
The 10 C3.ai Digital Transformation Institute consortium member universities and laboratories are: University of California, Berkeley, University of Illinois at Urbana-Champaign, Carnegie Mellon University, KTH Royal Institute of Technology, Lawrence Berkeley National Laboratory, Massachusetts Institute of Technology, National Center for Supercomputing Applications at University of Illinois at Urbana-Champaign, Princeton University, Stanford University, and University of Chicago. Additional industry partners include AstraZeneca, Baker Hughes, and Shell.
To support the Institute, C3 AI is providing the Institute $57,250,000 in cash contributions over the initial five years of operation. In addition to cash awards, C3.ai DTI provides researchers with cloud computing, supercomputing, data, and software resources, including free, unlimited use of the C3 AI Application Platform, up to $2 million in Azure Cloud computing resources, and access to High Performance Computing (HPC) resources at the National Center for Supercomputing Applications (NCSA) at the University of Illinois at Urbana-Champaign and Lawrence Berkeley National Laboratory’s National Energy Research Scientific Computing Center (NERSC).
About C3.ai, Inc.
C3 AI is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 AI Application Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications and C3 AI Applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally. Learn more at: www.c3.ai.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005202/en/
Contact information
C3.ai DTI Contact:
Kap Stann
Communications Manager, C3.ai DTI @ Berkeley
510-295-9685
kstann@berkeley.edu
C3 AI Public Relations:
Edelman
Lisa Kennedy
415-914-8336
pr@c3.ai
C3 AI Investor Relations
ir@c3.ai
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 13:38:00 EEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 12:48:00 EEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
